EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

03.06.08

USPTO As Broken as Always, Proof Herein

Posted in Free/Libre Software, Hardware, Patents at 2:03 am by Dr. Roy Schestowitz

Repeating the same mistakes of the drug industry

Whenever you find comfort in the belief that you have seen enough, here comes another disturbance. This one is from RIM.

What do you get if you mesh a dual-orientation handset together with a slide-out keyboard and a tracker ball? Potentially, the next BlackBerry from Research in Motion (RIM), if its latest patent application is anything to go by.

USPTOWhat RIM patents here has plenty of prior art and we recently saw an incident where RIM actually sued unnecessarily, attacking a weaker company like Motorola using weak patents applicable to wireless communication standards. The Nokia N810 and the Mylo from Sony seem rather similar to the design in this patent application, but this does not seem to bother or deter RIM. Remember what these people think: More Patents = More Innovation. But not so fast!

It seems like a patents blog has just shown up (or been born) in C|Net and it now speaks about the “first-to-file” rule, which renders the whole system utterly pointless and prone to error.

Generally, the first person to file the lawsuit gets to choose where the suit is brought. This is called the “first-to-file” rule. It works much like the lines you stand in at the grocery store, airport security, or countless other places; it’s simply first come, first served.

However, in the context of patent litigation, being first in line is a big deal. Different courts have different procedural rules that can affect the way a case is litigated and the speed at which the case goes to trial. Moreover, there is a perception that courts in certain areas are more plaintiff-friendly than others.

The term “first-to-file” is used in numerous other circumstances which equally well demonstrate the weakness of the whole approach. The pharmaceutical industry is already learning its lessons, so why can’t others?

Below we’re appending some relevant and recent stories about conclusions arrived by drug companies and biologists. They are sorted reverse-chronologically (roughly).


1. Open Lab

The open source wave could soon power drug discovery initiatives in the country. A decentralised, web-based initiative is emerging that would enable scientists from laboratories, universities, institutes, and drug Companies to work together in discovering new drugs for diseases like tuberculosis (TB), malaria, various types of cancer, AIDS, Chikungunya, Kala-azar, dengue fever, etc.

2. Open-source model for drug discovery?

Significant public funding along with the ability for private enterprise to benefit from the open source approach will result in a strong public-private partnership and ensure success of the open source approach.

3. Open source drug discovery

The idea, taking off from successful open source models such as the human genome sequencing initiative, is very simple. All the relevant data and accumulated intelligence on a particular disease, tuberculosis to begin with, would be hosted online.

4. ‘Open source’ urged for TB drug design effort

One of India’s top genetics researchers has called for a global, collaborative effort to design a new tuberculosis (TB) drug using an ‘open source’ approach.

5. Open Source Pharmaceuticals – New Business Model

Software is not the only field affected by open source; many fields of study and social and political views have been affected by the growth of the concept of open source. Advocates in one field will often support the expansion of open source in other fields, including Linus Torvalds who is quoted as saying, “the future is open source everything.”

6. Open source synthetic biology

Not everyone within synthetic biology takes the open-source approach, Andrew Hessel, an iGEM consultant who recruits teams from Canadian universities, told me, but the driving force behind it is iGEM and MIT (Rettberg works with renowned hacker-turned-synthetic biologist Tom Knight). Hessel likened the atmosphere to the time when computers were first becoming cheap enough to be affordable by anyone who wanted one, and young, bright kids began to play around with code.

7. Biology Goes Open Source

Some of the world’s biggest drug companies are finding that their genetic research is worth more to them if they give it away.

8. Pharmac publishes directly with open source

The team used Python, libxml/libxslt and TeX, running on Debian GNU/Linux, and the open document standards TeX, XML, MathML, XHTML, and Xlink, says Geering.

9. Open Source Research — the Power of Us

Open source methods have delivered tangible benefits in the computer science community. We describe here efforts to extend these principles to science generally, and in particular biomedical research. Open source research holds great promise for solving complex problems in areas where profit-driven research is seen to have failed. We illustrate this with a specific problem in organic chemistry that we think will be solved substantially faster with an open source approach.

10. Our Biotech Future [is Open Source]

Open Source biology could be a powerful tool, giving us access to cheap and abundant solar energy.

11. Open-Source Drug Safety?

More than a million Americans take Avandia every year; the risk Glaxo had found would mean thousands of extra heart attacks. But the company argued that the risk only occurred in patients who already had serious heart problems, and that it didn’t show up in long-term clinical trials. The FDA made no decision, and no public statement.

[...]

It’s an open source approach to drug safety.

12. Open Source Pharmaceuticals – New Business Model

“Open source” as applied to culture defines a culture in which intellectual property is made generally available. Participants in such a culture are able to improve and modify those products and redistribute them back into the community.

13. Thailand fed up with high drug prices – minister

“We have thought about this for more than five years. It’s long enough,” said Mongkol na Songkhla, who is leading one of the biggest challenges to Big Pharma’s patent rights in years.

In relation to this:

“Collaboration reduces development costs and subsequent high prices, and therefore precludes the need for patents. Took them long enough to figure that out, didn’t it?”

Slated, March 4th 2008

Time for change. Software patents do more harm than good.

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

A Single Comment

  1. mcintosh said,

    March 6, 2008 at 7:58 am

    Gravatar

    You want proof that our patent system is broken? Look up US patent number 6,960,975. Not only is there a metric (donkey)load of prior conceptual art in at least a half century’s science fiction, but reduction to practice is not presently possible.

What Else is New


  1. Links 22/5/2019: Mesa 19.0.5, Huawei and GNU/Linux, Curl 7.65.0, End of Antergos, Tails 3.14, ownCloud Server 10.2, Firefox 67.0

    Links for the day



  2. Quality of Patents is Going Down the Drain and Courts Have Certainly Noticed

    Uncertainty or lack of confidence in the patent system has reached appalling levels because heads of patent offices are just striving to grant as many patents as possible, irrespective of the underlying law



  3. EUIPO and EPO Abuses Growingly Inseparable

    'Musical chairs' at CEIPI and the EPO/EUIPO (Battistelli, Archambeau, Campinos) as well as joint reports never fail to reveal the extent to which EPO abuses are spreading



  4. Links 21/5/2019: China's GAFAM Exit, DragonFlyBSD 5.4.3

    Links for the day



  5. Links 20/5/2019: Linux 5.2 RC1, LibreOffice 6.3 Alpha, DXVK 1.2.1, Bison 3.4 Released

    Links for the day



  6. South Korea's Government Will Show If Microsoft Loves Linux or Just Attacks It Very Viciously Like It Did in Munich

    Microsoft's hatred of all things GNU/Linux is always put to the test when someone 'dares' use it outside Microsoft's control and cash cows (e.g. Azure and Vista 10/WSL); will Microsoft combat its longstanding urge to corrupt or oust officials with the courage to say "no" to Microsoft?



  7. Links 19/5/2019: KDE Applications 19.04.1 in FlatHub and GNU/Linux Adoption

    Links for the day



  8. The War on Patent Quality

    A look at the EPO's reluctance to admit errors and resistance to the EPC, which is its very founding document



  9. Watchtroll, Composed by Patent Trolls, Calls the American Patent System “Corrupt”

    Another very fine piece from Watchtroll comes from very fine patent trolls who cheer for Donald Trump as if he's the one who tackles corruption rather than spreading it



  10. Unified Patent Court Won't Happen Just Because the Litigation Microcosm Wants It

    Unified Patent Court (UPC) hopefuls are quote-mining and cherry-picking to manufacture the false impression that the UPC is just around the corner when in reality the UPC is pretty much dead (but not buried yet)



  11. Links 17/5/2019: South Korea's GNU/Linux Pivot, Linux 5.1.3

    Links for the day



  12. Q2 Midterm Weather Forecast for EPOnia, Part 4: Happy Birthday to the Kötter Group?

    This year the Kötter Group commemorates the 85th anniversary of its existence. But is it really a cause for celebration or would a less self-congratulatory approach be more fitting? And does it create the risk that a routine tendering exercise at the EPO will turn into Operation Charlie Foxtrot?



  13. Links 16/5/2019: Cockpit 194, VMware Acquires Bitnami, Another Wine Announcement and Krita 4.2.0 Beta

    Links for the day



  14. The EPO's Key Function -- Like the UPC's Vision -- Has Virtually Collapsed

    The EPO no longer issues good patents and staff is extremely unhappy; but the Office tries to create an alternate (false) reality and issues intentionally misleading statements



  15. Stanford's NPE Litigation Database Makes a Nice Addition in the Fight Against Software Patent Trolls

    As the United States of America becomes less trolls- and software patents-friendly (often conflated with plaintiff (un)friendliness) it's important to have accurate data which documents the numbers and motivates better policy; The NPE (troll) Litigation Database is a move towards that and it's free to access/use



  16. Q2 Midterm Weather Forecast for EPOnia, Part 3: “Ein kritikwürdiges Unternehmen”

    A brief account of some further controversies in which the Kötter Group has been involved and its strained relations with German trade unions such as Verdi



  17. EPO Had a Leakage Problem and Privacy of Stakeholders Was Compromised, Affecting at Least 100 Cases

    The confidentiality principle was compromised at the EPO and stakeholders weren't told about it (there was a coverup)



  18. Links 15/5/2019: More Linux Patches and More Known Intel Bugs

    Links for the day



  19. False Hope for Patent Maximalists and Litigation Zealots

    Patent litigation predators in the United States, along with Team UPC in Europe, are trying to manufacture optimistic predictions; a quick and rather shallow critical analysis reveals their lies and distortions



  20. The Race to the Bottom of Patent Quality at the EPO

    The EPO has become more like a rubber-stamper than a patent office — a fact that worries senior staff who witnessed this gradual and troublesome transition (from quality to raw quantity)



  21. Q2 Midterm Weather Forecast for EPOnia, Part 2: Meet the Kötters

    An introduction to the Kötter Group, the private security conglomerate which is lined up for the award of a juicy EUR 30 million contract for the provision of security services at the EPO



  22. Links 14/5/2019: Red Hat Satellite 6.5, NVIDIA 430.14 Linux Driver and New Security Bug (MDS)

    Links for the day



  23. Links 14/5/2019: GNU/Linux in Kerala, DXVK 1.2, KDE Frameworks 5.58.0 Released

    Links for the day



  24. Q2 Midterm Weather Forecast for EPOnia, Part 1: Urgent Shitstorm Alert

    Experts at the European Patent Office's (EPO) weather observation station have just issued an urgent alert warning about a major shitstorm looming on the horizon



  25. Patents That Were Gleefully Granted by the EPO Continue to Perish in Courts

    The decreasing quality of granted European Patents already becomes a growing problem if not a crisis of uncertainty



  26. Links 13/5/2019: ExTiX 19.5 and GNU Radio Conference 2019

    Links for the day



  27. The Microsoft Guide to the Open Source Galaxy

    Thou shalt not...



  28. Microsoft Would Kill the Goose for Money

    Microsoft is just 'monetising' Open Source by using it as 'bait' for Microsoft's proprietary software; those who we might expect to antagonise this have effectively been bribed by Microsoft



  29. Links 13/5/2019: Nanonote 1.2.0, OpenMandriva Lx 4.0 RC, and GNUnet 0.11.4

    Links for the day



  30. Professionally Incompetent EPO Management

    The EPO remains an awful employer, with top-level management largely responsible for the loss of talent and even money


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts